Literature DB >> 16293641

Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.

Jason Matthews1, Björn Wihlén, Michel Tujague, Jinghong Wan, Anders Ström, Jan-Ake Gustafsson.   

Abstract

In this study, an estrogen receptor (ER) alpha-expressing T47D cell line containing an inducible tet-off FLAG-ERbeta was used to examine the influence of ERbeta on ERalpha activity. Real-time PCR analysis of mRNA levels of two well-studied estrogen-responsive genes, pS2 and progesterone receptor (PR), showed that the expression levels of both genes were reduced in the presence of ERbeta. Chromatin immunoprecipitation assays showed that the 17beta-estradiol (E2)-induced recruitment patterns to the pS2 and PR promoters were similar for both ERalpha and ERbeta. ERbeta expression did not significantly influence the kinetic recruitment profile of ERalpha to the pS2 promoter, but it was evident that ERalpha occupancy at the PR promoter was reduced. The E2-induced recruitment of c-Fos to a 12-O-tetradecanoylphorbol-13-acetate response element site in the PR promoter was significantly reduced in the presence of ERbeta, whereas only a slight reduction in the recruitment of c-Fos to the pS2 promoter was observed. ERbeta expression resulted in a significant reduction in the E2-induced expression of c-Fos mRNA. The recruitment pattern of c-Jun was also altered by ERbeta, although the expression levels of c-Jun were not. Expression of ERbeta caused a further 30-50% decrease of the E2-induced reduction in ERalpha protein after 3 h of E2 treatment, showing that ERbeta influences ERalpha protein levels. The altered recruitment of the activating protein-1 complex, combined with the reduction in ERalpha protein levels, may partly explain the antagonistic effect of ERbeta on ERalpha-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293641     DOI: 10.1210/me.2005-0140

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  61 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Cutting SRC-1 down to size in endometriosis.

Authors:  Matthew T Dyson; Serdar E Bulun
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 3.  Role of estrogen receptor-β in endometriosis.

Authors:  Serdar E Bulun; Diana Monsavais; Mary Ellen Pavone; Matthew Dyson; Qing Xue; Erkut Attar; Hideki Tokunaga; Emily J Su
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

4.  The genome landscape of ERalpha- and ERbeta-binding DNA regions.

Authors:  Yawen Liu; Hui Gao; Troels Torben Marstrand; Anders Ström; Eivind Valen; Albin Sandelin; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

5.  Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent manner.

Authors:  Ming-Tsung Lee; Yuet-Kin Leung; Irving Chung; Pheruza Tarapore; Shuk-Mei Ho
Journal:  J Biol Chem       Date:  2013-07-15       Impact factor: 5.157

6.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

7.  Estradiol increases ER-negative breast cancer metastasis in an experimental model.

Authors:  Xujuan Yang; Aashvini Belosay; Mengyuan Du; Timothy M Fan; Russell T Turner; Urszula T Iwaniec; William G Helferich
Journal:  Clin Exp Metastasis       Date:  2013-10-05       Impact factor: 5.150

Review 8.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

9.  hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

Authors:  S P Sripathy; L J Chaplin; N W Gaikwad; E G Rogan; M M Montano
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

Review 10.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.